US to wrap criminal trial of Insys Therapeutics' executives tied to opioid crisis Medical Dialogues Bureau6 April 2019 8:59 AM ISTBOSTON: Prosecutors on Thursday will present their closing arguments in the trial of the wealthy founder of pharmaceutical company Insys Therapeutics...
Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan Farhat Nasim13 March 2019 1:49 PM ISTValsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney...
OxyContin maker Purdue Pharma exploring bankruptcy: Report Farhat Nasim5 March 2019 9:20 AM ISTSales of OxyContin and other opioids have fallen amid public concern about their addictive nature, and as restrictions on opioid prescribing have been...
Supreme Court lifts ban on Saridon, major relief to Piramal Meghna A Singhania21 Feb 2019 6:05 PM ISTNew Delhi: In a major relief to Piramal, the Supreme Court has exempted the popular painkiller drug Saridon from the list of Fixed Dose Combinations...
Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril Farhat Nasim7 Feb 2019 2:23 PM ISTLupin had a net loss of 1.52 billion rupees compared to a profit of 2.22 billion rupees in the same quarter last year, the company said.Mumbai: A...
Fall in customs duty likely on certain medical devices Medical Dialogues Bureau22 Jan 2019 2:04 PM ISTIndustry chamber CII in its has pre-budget memorandum has asked the government to reduce customs duty from 10 per cent to 2.5 per cent on PDS Plates...
Pfizer shutdown at Chennai, Aurangabad: Employees offered Severance Package Farhat Nasim14 Jan 2019 2:06 PM ISTChennai: While shutting down plants at two major cities in the country, drug maker Pfizer is now trying to strike a deal with its 1700 employees at...
Pfizer to shut shop at Chennai, Aurangabad units, 1700 employees in lurch Farhat Nasim10 Jan 2019 11:12 AM ISTNew Delhi: For more than 60 years of commercial and manufacturing presence in India, drug major Pfizer recently decided to shut down its...
Sanofi to pay Regeneron $462 million in revised immuno-oncology deal Farhat Nasim9 Jan 2019 9:15 AM ISTSanofi will pay Regeneron $462 million representing the balance of payments due under their original deal, which covers the Sanofi share of the...
Lupin receives FDA approval for Lurasidone Hydrochloride Tablets Farhat Nasim7 Jan 2019 9:45 AM ISTLupin's Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg is the generic version of Sunovion Pharmaceuticals, Inc's Latuda...
Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years Farhat Nasim5 Jan 2019 10:44 AM ISTNew Delhi: Through a recent Gazette notice the Central Government has made amendments to the Drugs Prices Control Orders (DPCO),2013 which aim to...
Lupin receives FDA approval for Clobazam Oral Suspension Farhat Nasim1 Jan 2019 10:00 AM ISTLupin's Clobazam Oral Suspension, 2.5 mg/mL is the generic version of Lundbeck Pharmaceuticals, LLC's Onfi Oral Suspension, 2.5 mg/mL. It is indicated...
